Skip to content
IMUXImmunic, Inc.

Earnings

When Immunic, Inc. reports, what it reported each quarter, and how the stock took the results.

55 quarters. Mar 31, 2013 to Sep 30, 2026. mixed units.

Next results · Q4 2026Projected

Feb 25, before the open

Thu, Feb 25, 2027in 99 days

Projected from its last 8 releases. The company has not named the day yet.

Quarter
Q4 2026 · Ends about Dec 31, 2026
10-K window
Feb 22 – Mar 19

Read against Q4 2025

The same quarter a year earlier, the figures the next ones will be compared with. Thaler holds no estimates.

Revenue
—
Net income
-$19.30M
Net income, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q4 2025 n/m
EPS
—
EPS, change from a year earlier: Q3 2026 n/m, Q2 2026 n/m, Q1 2026 n/m, Q3 2025 n/m

Quarter by quarter

Q3 2026-$42.31MNo Q3 2025 on file

Latest results

  1. Q3 2026Nov 13, 2026, before the openThe release
    Revenue
    —
    —
    Net income
    -$42.31M
    N/M
    EPS
    -$0.99
    N/M
    Immunic, Inc. Reports Third Quarter 2026 Financial Results and Provides Corporate Update
  2. Q2 2026Aug 11, 2026, before the openThe release+9.8%by the close of Aug 11
    Revenue
    —
    —
    Net income
    -$34.10M
    N/M
    EPS
    -$0.80
    N/M
  3. Q1 2026May 13, 2026, before the openThe release+8.8%by the close of May 13
    Revenue
    —
    —
    Net income
    -$32.59M
    N/M
    EPS
    -$1.08
    N/M
  4. Q4 2025Feb 26, 2026, before the openThe release+4.3%by the close of Feb 26
    Revenue
    —
    —
    Net income
    -$19.30M
    N/M
    EPS
    —
    —

All quarters

PeriodEndedAnnouncedFiledLagFormRevenueΔ yoyEPS dil.MoveSource trail
FY 2026
Q3 2026Sep 30, 2026Nov 13, 2026 · pre-marketNov 13, 202644 d10-Q——-$0.99—
Q2 2026Jun 30, 2026Aug 11, 2026 · pre-marketAug 11, 202642 d10-Q——-$0.80+9.8%
Q1 2026Mar 31, 2026May 13, 2026 · pre-marketMay 13, 202643 d10-Q——-$1.08+8.8%
FY 2025
Q4 2025derivedDec 31, 2025Feb 26, 2026 · pre-marketFeb 26, 202657 d10-K———+4.3%
Q3 2025Sep 30, 2025Nov 13, 2025 · pre-marketNov 13, 202544 d10-Q——-$1.326.6%
Q2 2025Jun 30, 2025Aug 7, 2025 · pre-marketAug 7, 202538 d10-Q——-$2.038.2%
Q1 2025Mar 31, 2025—May 15, 202545 d10-Q——-$2.512.6%
FY 2024
Q4 2024derivedDec 31, 2024—Mar 31, 202590 d10-K———8.8%
Q3 2024Sep 30, 2024Nov 7, 2024 · pre-marketNov 7, 202438 d10-Q——-$0.241.3%
Q2 2024Jun 30, 2024Aug 8, 2024 · pre-marketAug 8, 202439 d10-Q——-$0.21+4.7%
Q1 2024Mar 31, 2024May 8, 2024 · pre-marketMay 8, 202438 d10-Q——-$0.305.2%
Earlier years, FY 2013 to FY 2023

Move: the stock from the last close before the release to the first close after it. Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Source filings

10-QNov 13, 2026000021
10-QAug 11, 2026000018
10-QMay 13, 2026000010
10-KFeb 26, 2026000005
10-QNov 13, 2025000017
10-QAug 7, 2025000012
10-QMay 15, 2025000008
10-KMar 31, 2025000005
10-QNov 7, 2024000018
10-QAug 8, 2024000014

Provenance

ProvenanceData status and checks

Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR